LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹111 Cr | ₹93 Cr | ₹194 Cr | ₹86 Cr | ₹61 Cr |
What is the latest Revenue of LYKA LABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹86 Cr |
| Mar2021 | ₹61 Cr |
How is Revenue of LYKA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 19.47 | |
| Mar2024 | ₹93 Cr | -52.05 | |
| Mar2023 | ₹194 Cr | 125.02 | |
| Mar2022 | ₹86 Cr | 40.27 | |
| Mar2021 | ₹61 Cr | - | |
Compare Revenue of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹255.0 Cr | -0% | -15.8% | -50.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0% |
-15.8% |
-50.8% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses